Pomalong 4 mg Capsule

About Pomalong 4 mg Capsule

Pomalong 4 mg Capsule is a potent immunomodulatory agent designed to combat multiple myeloma, a challenging form of blood cancer that affects plasma cells. This medication is specifically indicated for patients who have already undergone at least two prior treatments, including lenalidomide and a proteasome inhibitor, making it an important option in advanced cancer care. Pomalong works by enhancing the immune response against cancer cells, thereby inhibiting their growth and proliferation. While effective, it is crucial for patients to be aware of potential side effects, which may include fatigue, increased risk of infections, and blood-related issues. Regular monitoring by healthcare professionals is essential to ensure patient safety and optimize treatment outcomes. Pomalong represents a valuable addition to the therapeutic arsenal for those battling relapsed or refractory multiple myeloma. Always consult your healthcare provider for personalized advice and to discuss any possible interactions with other medications.